Is Chinese Healthcare the Miracle KURE for Your Portfolio? April 5, 2021
In the United States, healthcare is a dynamic sector home to defensive value stocks, disruptive growth names, and plenty of in-between.
China offers a comparable level of healthcare dynamism, which investors can access with exchange traded funds such as the
KURE invests in a variety of publicly traded shares of Chinese issuers, including A-Shares, B-Shares, H-Shares, P-Chips, and Red Chips – the portfolio essentially includes companies listed on mainland China, Hong Kong, and the U.S. Furthermore, the Chinese healthcare companies must be classified under the Global Industry Classification Standard. That index may also include small-, mid- and large-cap companies.